{"id":7588,"date":"2022-09-16T10:40:57","date_gmt":"2022-09-16T05:10:57","guid":{"rendered":"http:\/\/finservwealth.com\/mc-exclusive-manforce-condoms-maker-mankind-pharma-files-papers-for-700-mn-plus-ipo-one-of-the-biggest-ever-in-sector\/"},"modified":"2022-09-16T10:40:57","modified_gmt":"2022-09-16T05:10:57","slug":"mc-exclusive-manforce-condoms-maker-mankind-pharma-files-papers-for-700-mn-plus-ipo-one-of-the-biggest-ever-in-sector","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/mc-exclusive-manforce-condoms-maker-mankind-pharma-files-papers-for-700-mn-plus-ipo-one-of-the-biggest-ever-in-sector\/","title":{"rendered":"MC Exclusive | Manforce condoms maker Mankind Pharma files papers for $700 mn plus IPO; one of the biggest ever in sector"},"content":{"rendered":"<p> In 2015, Capital International had purchased a 11 percent stake in Mankind Pharma from ChrysCapital for $200 million. In April 2018, a ChrysCapital-led consortium, which included GIC and CPPPIB, made a stunning comeback and bought a 10 percent stake again for around $350 million. Earlier in the year, Mankind Pharma had acquired the formulations brands of listed player Panacea Biotec in India and Nepal for  Rs 1,872 crore to explore new therapeutic areas.<\/p><div id=\"finse-1202097498\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/mc-exclusive-%7C-manforce-condoms-maker-mankind-pharma-files-papers-for-36700-mn-plus-ipo-onethe-biggest-eversector_16625221.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>In 2015, Capital International had purchased a 11 percent stake in Mankind Pharma from ChrysCapital for $200 million. In April 2018, a ChrysCapital-led consortium, which included GIC and CPPPIB, made a stunning comeback and bought a 10 percent stake again for around $350 million. Earlier in the year, Mankind Pharma had acquired the formulations brands&hellip;&nbsp;<a href=\"https:\/\/finservwealth.com\/hi\/mc-exclusive-manforce-condoms-maker-mankind-pharma-files-papers-for-700-mn-plus-ipo-one-of-the-biggest-ever-in-sector\/\" rel=\"bookmark\">\u0914\u0930 \u092a\u0922\u093c\u0947\u0902 &raquo;<span class=\"screen-reader-text\">MC Exclusive | Manforce condoms maker Mankind Pharma files papers for $700 mn plus IPO; one of the biggest ever in sector<\/span><\/a><\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-7588","post","type-post","status-publish","format-standard","hentry","category-latest-news"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/7588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=7588"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/7588\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=7588"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=7588"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=7588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}